Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Education and support program for African American patients with advanced kidney disease

Official title: Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy

Run by University of Chicago · NCT06397456 · Data updated 2026-11-12

This study is testing a 12-week education and support program for African American patients with advanced kidney disease to see if it helps them better manage their condition and plan for treatment.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment180 (estimated)
SponsorUniversity of Chicago
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedSeptember 4, 2024
Main results expectedApril 30, 2026
Study endsJune 30, 2026
Registry record updatedNovember 14, 2025
Trial IDNCT06397456 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are hospitalized African American patients aged 18 to 70 with advanced CKD (Stage 3B or above).

Probably not a fit

Patients who are non-English speaking, unable to communicate due to their medical status, or currently admitted to the ICU may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Intensive Patient Referral and Education Program prior to Renal Replacement Therapy (iPREP-RRT) is a 12-week intervention designed for hospitalized African Americans with advanced chronic kidney disease (CKD). This program provides hospital- and community-based education, navigation, and self-management support to improve patient knowledge and self-efficacy regarding CKD and renal replacement therapy (RRT) planning. Participants will be randomized to receive either the iPREP-RRT intervention or enhanced usual care, with the aim of enhancing CKD self-management and RRT planning through various communication methods. The study evaluates the effectiveness of both hospital-based and community-based interventions in improving patient outcomes.

Why it matters

Potential benefit: If successful, this program could significantly enhance the self-management and treatment planning for African American patients with advanced CKD.

How similar studies have gone: Other studies have shown success with similar educational and support interventions for chronic disease management, indicating potential for positive outcomes in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients over the age of 18 and under 70
* Admitted to the University of Chicago inpatient general medicine service
* Likely hospital stay greater than 48 hours
* Diagnosis of advanced CKD (Stage 3B or above, as determine by problem list, ICD- 10 codes or eGFR\<45 during admission and from previous medical encounters)
* Self-identify as Black or African American

Exclusion Criteria:

* Non-English speaking
* Unable to communicate due to current medical status
* Unable to consent due to mental status
* Expected hospital stay less than 24 hour
* Current admission in ICU

Where it's running

  • University of Chicago Medical Center
    Chicago, Illinois, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.